TABLE 5.
Circulating lipid levels before and after sleeve gastrectomy.
| Non‐diabetes n = 11 | Within group effects of SG | Diabetes N = 8 | Within group effects of SG | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 6W | 6M | Baseline | 6W | 6M | |||
| Total cholesterol (mg/dL) | 183 ± 37 | 150 ± 29** | 173 ± 39 | F = 10.6, p < 0.001 | 182 ± 42 | 165 ± 32 | 174 ± 30 | NS |
| Triglycerides (mg/dL) | 122 ± 63.6 | 87 ± 28.1* | 78 ± 25.0* | F = 5.2, p = 0.03 | 182 ± 61 | 111 ± 32* | 100 ± 47* | F = 7.2, p = 0.01 |
| HDL (mg/dL) | 51 ± 21.3 | 44 ± 10.9 | 54 ± 12.7‡ | F = 4.2, p = 0.029 | 40 ± 8.4 | 36 ± 4.5† | 53 ± 8.0* | F = 29, p < 0.001 |
| LDL (mg/dL) | 109 ± 29 | 88 ± 22.1** | 103 ± 31.7 | F = 5.6, p = 0.01 | 105 ± 33.4 | 107 ± 31.1 | 101 ± 21.6 | NS |
Abbreviation: NS, not significant.
Post‐hoc Bonferroni comparison: *p < 0.05, compared to baseline, within group comparison. **p < 0.01, compared to baseline, within group comparison. † p < 0.05, group comparison at the same time point. ‡ p < 0.05, increase in HDL at 6M compared to 6W in the non‐diabetic group.